Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice-Reference-Cited by-同舟云学术

Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice

Published:2007-06 Issue:6 Volume:63 Page:715-721
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Moltó José,Blanco Asunción,Miranda Cristina,Miranda José,Puig Jordi,Valle Marta,DelaVarga Meritxell,Fumaz Carmina R.,Barbanoj Manuel José,Clotet Bonaventura

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2006.02834.x/fullpdf

Reference30 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

3. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

4. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

5. Therapeutic drug monitoring in HIV infection: current status and future directions

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of CYP2B6 polymorphisms on plasma nevirapine concentrations: a systematic review and meta-analysis;Scientific Reports;2020-10-15

2. Clinical and genetic determinants of nevirapine plasma trough concentration;SAGE Open Medicine;2018-01-01

3. Efficacy and safety of switching from nevirapine immediate-release twice daily to nevirapine extended-release once daily in virologically suppressed HIV-infected patients: a retrospective cohort study in Taiwan;BMC Infectious Diseases;2017-04-11

4. A pharmacist’s role in the individualization of treatment of HIV patients;Personalized Medicine;2016-03

5. Therapeutic Drug Monitoring of Antiretrovirals;Clinical Challenges in Therapeutic Drug Monitoring;2016